Target intelligence / Profile preview

Ankyrin repeat family A protein 2 (ANKRA2)

Target
ANKRA2
Molecular classification
Other (Ankyrin repeat-containing protein), Transcription regulator/cellular cofactor
01

Overview

Ankyrin repeat family A protein 2 (ANKRA2) is a scaffold protein characterized by four tandem ankyrin repeat domains, which mediate selective protein–protein interactions. It functions as a regulatory cofactor in cellular complexes, especially by binding to class II histone deacetylases (HDAC4, HDAC5, HDAC9) to facilitate signal-responsive transcriptional repression. ANKRA2 also interacts with plasma membrane proteins such as the megalin receptor and the BKCa potassium channel, suggesting roles in endocytosis and ion channel regulation. In the nucleus, ANKRA2 modulates transcription by acting as a coregulator with RFX family transcription factors, including RFX7, primarily in the context of DNA damage response and p53 signaling. While paralogous to RFXANK, ANKRA2 preferentially complexes with RFX7 and is implicated in the induction of tumor suppressor genes such as PDCD4 and PIK3IP1 upon cellular stress. Currently, ANKRA2 is not a validated drug target, but its roles in epigenetic regulation and immune-related transcription make it biologically significant and a candidate for further investigation in disease biology.

Other names
Ankyrin repeat family A member 2ANKRARFXANK-like protein 2ankyrin repeat family A protein 2ankyrin repeat, family A (RFXANK-like), 2
02

Mechanism of action

Not applicable (No drugs directly target ANKRA2; however, class II HDAC inhibitors could theoretically disrupt its protein–protein complexes indirectly)

03

Biological functions

Protein–protein interaction scaffoldRegulation of protein-containing complex assemblyRegulation of chromatin-modifying enzymes and transcriptional repression (by interacting with class II HDACs)Modulation of low-density lipoprotein receptor (megalin/LRP2) and ion channel (BKCa potassium channel)Cofactor for transcription factor RFX7 and downstream DNA damage response and p53 signaling
04

Disease associations

ImmunodeficiencyFamilial hypercholesterolemiaCancerOther (Transcriptional regulation of pathways relevant to immune signaling)
05

Safety considerations

None reported
06

Interacting drugs

None reported
07

Biomarkers

None clinically established

Beyond the preview

Go deeper on Ankyrin repeat family A protein 2 (ANKRA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat family A protein 2 (ANKRA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call